Literature DB >> 24020908

Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long-term follow-up study.

Patrizia Bruzzi1, Barbara Predieri, Viviana Dora Patianna, Annamaria Salvini, Rosario Rossi, Maria Grazia Modena, Lorenzo Iughetti.   

Abstract

BACKGROUND: Type 1 diabetes (T1DM) predisposes to cardiovascular disease, increasing the risk to develop atherosclerosis. In the pediatric population, the cardiovascular risk may be evaluated examining endothelial function by a non-invasive ultrasound technique, namely flow-mediated dilation (FMD) of the brachial artery. The aims of this study were the longitudinal evaluation of the potential change in the endothelium-dependent vasomotor function in children and adolescents with T1DM and the identification of clinical and laboratory data correlated to modifications.
METHODS: We studied 39 T1DM patients (20 girls and 19 boys; aged 11.2 ± 3.72 years). FMD and blood samples were obtained from all patients at baseline (time 0) and after a follow up of at least 1 year (time 1). FMD was also evaluated in 45 healthy controls (22 boys, 23 girls) aged 10.2 ± 3.05 years.
RESULTS: At time 0, 43.6% of T1DM patients presented an impaired FMD. FMD at time 1 revealed a dramatic impairment of endothelial function: altered FMD values were shown in 61.5% of patients and it got worse in 74.3% of them. Longitudinally, boys had a greater impairment of FMD than girls. At baseline, multivariate analysis identified only sex as significant predictor of FMD (β = 0.470, P = 0.029).
CONCLUSIONS: Because endothelial dysfunction appears earlier in diabetic children, they are at higher risk to develop atherosclerosis. Our results suggest the usefulness of FMD as a tool to stratify pediatric T1DM patients according to their cardiovascular risk and to follow them up longitudinally.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Keywords:  atherosclerosis; endothelial function; flow-mediated dilation; glycosylated hemoglobin; type 1 diabetes mellitus

Mesh:

Year:  2014        PMID: 24020908     DOI: 10.1111/ped.12220

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  6 in total

Review 1.  Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes.

Authors:  Marcello C Bertoluci; Gislaine V Cé; Antônio Mv da Silva; Marco V Wainstein; Winston Boff; Marcia Puñales
Journal:  World J Diabetes       Date:  2015-06-10

Review 2.  Prognostic value of endothelial dysfunction in type 1 diabetes mellitus.

Authors:  Ana Marice Ladeia; Raphael Ribeiro Sampaio; Maiara Costa Hita; Luis F Adan
Journal:  World J Diabetes       Date:  2014-10-15

Review 3.  The Impact of Diabetes Mellitus on Cardiovascular Risk Onset in Children and Adolescents.

Authors:  Ida Pastore; Andrea Mario Bolla; Laura Montefusco; Maria Elena Lunati; Antonio Rossi; Emma Assi; Gian Vincenzo Zuccotti; Paolo Fiorina
Journal:  Int J Mol Sci       Date:  2020-07-12       Impact factor: 5.923

4.  Early Endothelial Dysfunction in Type 1 Diabetes Is Accompanied by an Impairment of Vascular Smooth Muscle Function: A Meta-Analysis.

Authors:  Elodie Lespagnol; Luc Dauchet; Mehdi Pawlak-Chaouch; Costantino Balestra; Serge Berthoin; Martin Feelisch; Matthieu Roustit; Julien Boissière; Pierre Fontaine; Elsa Heyman
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-17       Impact factor: 5.555

5.  Assessment of Microvascular Function in Children and Adolescents with Diabetes and Obesity.

Authors:  Elna Kochummen; Vatcharapan Umpaichitra; Albara Marwa; Krittika Joshi; Vivian L Chin; Sheila Perez-Colon
Journal:  Int J Endocrinol Metab       Date:  2019-12-29

6.  Do patients with type 1 and type 2 diabetes really have an impaired endothelial function? A population-based propensity score matching analysis.

Authors:  Klaus Empen; Roberto Lorbeer; Henry Völzke; Thorsten Reffelmann; Sabine Schipf; Matthias Nauck; Wolfgang Kerner; Henri Wallaschofski; Stephan B Felix; Marcus Dörr
Journal:  Cardiovasc Diabetol       Date:  2013-12-05       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.